Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340152 · ClinicalTrials.gov registry record
Multi-Omics for Maternal Health After Preeclampsia
A clinical trial of Pre-Eclampsia and Pregnancy Induced Hypertension, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 1,100
- Enrollment target
- 1
- Study location
NCT06340152 is a study of Pre-Eclampsia and Pregnancy Induced Hypertension that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 1,100 participants, above the 370-participant average among 8 other Pre-Eclampsia trials with a reported enrollment target (197% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06340152, a study of Pre-Eclampsia and Pregnancy Induced Hypertension, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 1,100 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
Conditions Studied
Study Locations (1)
California
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2023-12-20 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06340152
The ClinicalTrials.gov registry entry for NCT06340152 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 370-participant average among 8 other Pre-Eclampsia trials with a reported enrollment target (197% higher). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pre-Eclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT06340152 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06340152 about?
NCT06340152 is a clinical study titled "Multi-Omics for Maternal Health After Preeclampsia". To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
What is the current status of trial NCT06340152?
This trial is currently recruiting. The enrollment target is 1,100 participants. The study started on 2023-12-20. Estimated completion is 2028-12.
What conditions does trial NCT06340152 study?
This clinical trial studies the following conditions: Pre-Eclampsia, Pregnancy Induced Hypertension.
Who is sponsoring clinical trial NCT06340152?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06340152 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre-Eclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
-
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
RECRUITING · Phase 3
-
Physical Activity to Mitigate PreEclampsia Risk
RECRUITING · NA
-
Mechanisms of Pregnancy Vascular Adaptations
RECRUITING
-
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.